Know Cancer

or
forgot password

Dosimetric Planning Study Comparing IMRT and 4-field Radiotherapy for Definitive Treatment of Cancer of the Cervix


Phase 0
N/A
N/A
Not Enrolling
Female
Cervix Cancer

Thank you

Trial Information

Dosimetric Planning Study Comparing IMRT and 4-field Radiotherapy for Definitive Treatment of Cancer of the Cervix


Radiotherapy in combination with chemotherapy is the standard treatment of locally advanced
cervix cancer, however with traditional techniques large volumes of bowel and bladder are
irradiated causing short-term and long-term genito-urinary and gastro-intestinal side
effects. IMRT has the potential to conform precisely to the target and spare normal tissues
and reduce side effects. However because there are large dose gradients there is the
potential to miss the target due to organ motion. Recent studies have documented organ
motion and will be used to define the target. Approximately 60 planning scans, previously
used to treat patients with cervix cancer, will be used to replan using an IMRT technique
and differences in doses to tumour and normal tissues compared.


Inclusion Criteria:



- last 60 patients treated definitively for cervical cancer at Sunnybrook Odette Cancer
Centre

Exclusion Criteria:

- no imaging and no anatomical description of disease

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Reduction in dose to organs at risk

Outcome Time Frame:

6 months

Safety Issue:

No

Principal Investigator

Gillian Thomas, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Sunnybrook Health Sciences Centre

Authority:

Canada: Ethics Review Committee

Study ID:

IMRTCC

NCT ID:

NCT00981552

Start Date:

December 2008

Completion Date:

September 2009

Related Keywords:

  • Cervix Cancer
  • Cervix Cancer
  • IMRT
  • Organ Motion
  • Target Definition
  • Uterine Cervical Neoplasms

Name

Location